C
Caresyntax
Digital surgery platform that uses proprietary software and AI to deliver actionable insights to improve patient outcomes
About Caresyntax
Caresyntax is a healthcare technology startup that operates in the surgical data analytics space. The company provides software, data, and professional services solutions to optimize surgical procedures, improve patient outcomes, and enhance operational efficiency in hospitals and clinics. Its primary clients are surgeons and their teams, as well as large, for-profit hospitals and university hospitals.
Read full description
Caresyntax's business model revolves around its vendor-neutral, enterprise-scale surgical technology data platform. This platform collects and analyzes data from surgical procedures to support decision-making, enhance surgical techniques, and improve team dynamics. The goal is to reduce unwarranted variation in surgical procedures, thereby increasing patient safety and satisfaction.
The company also offers video-based assessments and analytics to improve surgical skills and team dynamics. These services have been used by institutions such as the University of Iowa Hospitals and Clinics and the Hôpitaux Universitaires de Strasbourg to improve their surgical procedures.
Caresyntax generates revenue by selling its software and services to hospitals and clinics. The company's solutions have been deployed in 2,800 operating rooms worldwide, supporting more than 32,000 surgical teams and improving care for more than 3 million patients per year.
In summary, Caresyntax is a healthcare technology company that uses data analytics to improve surgical procedures and patient outcomes, while also enhancing operational efficiency in hospitals and clinics.
At a glance
- Founded
- 2013
- Headquarters
- Boston, United States
- Sector
- Health Tech & Medtech
- Power Law
- Colt$25–100M revenue
Latest news
Press, funding announcements and product moves mentioning Caresyntax.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
Norgine Ventures
Surgical.AI
Plug and Play
IPF Partners
Mitsubishi
Whiz Partners
Series B and later15 investors entered at this stage
PFM Health Sciences
Lauxera Capital Partners
Intel Capital
Optum Ventures
Harmonix- ACArno Capital
BlackRock
ProAssurance
Relyens
Vesalius Biocapital Partners- RIRezayat Investments
MTIP
Symbiotic Capital
Pictet
Aescuvest
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Market sentiment
An AI-synthesised read of the highest-engagement posts about Caresyntax on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Caresyntax on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.